AMD vs DHR: Which Is the Better Buy?
Side-by-side comparison of Advanced Micro Devices, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
Advanced Micro Devices, Inc. · Technology
$614.61
-13.7% upside to fair value
Med Conviction
Grade C
VS
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AMD |
DHR |
| Current Price |
$614.61 |
$221.12 |
| Fair Value Estimate |
$530.25 |
$286.52 |
| Upside to Fair Value |
-13.7%
|
+29.6%
|
| Market Cap |
$1,002.2B |
$155.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
93.4x
|
24.8x
|
| Price / Sales |
24.3x
|
6.2x
|
| Price / FCF |
119.3x
|
28.5x
|
| Revenue Growth YoY |
+50.1%
|
+5.5%
|
| Gross Margin |
53.2%
|
58.5%
|
| Operating Margin |
15.7%
|
20.4%
|
| Return on Equity |
10.1%
|
7.7%
|
| Dividend Yield |
0% |
0.65% |
| FCF Yield |
0.84%
|
3.51%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Advanced Micro Devices designs x86 CPUs, GPUs, and data-center accelerators across two segments, Computing and Graphics and Enterprise, Embedded and Semi-Custom, with 31,000 employees and a $1.002 trillion market capitalization at $614.61 per share. The business quality is genuinely improving: revenue grew 50.1% year over year in the most recent quarter, earnings grew 163.4% year over year in the…
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Accumulation Zones
| Metric |
AMD |
DHR |
| Zone Low |
$397.69 |
$214.89 |
| Zone High |
$450.71 |
$243.54 |
| In Buy Zone? |
No
|
Yes
|